News

Sanofi (SNY, Financials) Completes Opella Deal, Creates Consumer Health Leader
Sanofi reported net cash proceeds of about 10 billion ($10.7 billion) from the deal, which it had outlined earlier in 2024.
Opella Launches As An Independent Company To Redefine The Future Of Self-Care.
Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling sta ...
Fierce Pharma5d
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals
Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal ...
Medical Dialogues3d
Sanofi sells controlling stake of consumer healthcare business Opella
Paris: Sanofi has announced the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business ...
Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus
Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.
Morningstar5d
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R ...
Finanznachrichten5d
Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a ...